Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.

Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 24 8 2018
medline: 24 8 2018
entrez: 24 8 2018
Statut: ppublish

Résumé

This Article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.

Identifiants

DOI: 10.1038/s41431-018-0216-1 PMID: 30135485 PMC: PMC6303246
pubmed: 30135485
doi: 10.1038/s41431-018-0216-1
pii: 10.1038/s41431-018-0216-1
pmc: PMC6303246
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

167-168

Commentaires et corrections

Type : ErratumFor

Auteurs

Logan C Walker (LC)

Department of Pathology, University of Otago, Christchurch, New Zealand. logan.walker@otago.ac.nz.

Louise Marquart (L)

Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

John F Pearson (JF)

Biostatistics and Computational Biology Unit, Department of the Dean, University of Otago, Christchurch, New Zealand.

George A R Wiggins (GAR)

Department of Pathology, University of Otago, Christchurch, New Zealand.

Tracy A O'Mara (TA)

Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Michael T Parsons (MT)

Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Daniel Barrowdale (D)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.

Lesley McGuffog (L)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.

Joe Dennis (J)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.

Javier Benitez (J)

Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.

Thomas P Slavin (TP)

Department of Population Sciences Division of Clinical Cancer Genomics, City of Hope Clinical Cancer Genomics Community Research Network, Duarte, CA, USA.

Paolo Radice (P)

Department of Preventive and Predictive Medicine, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.

Debra Frost (D)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.

Andrew K Godwin (AK)

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

Alfons Meindl (A)

Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Rita Katharina Schmutzler (RK)

Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne, Germany.

Claudine Isaacs (C)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.

Beth N Peshkin (BN)

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.

Trinidad Caldes (T)

Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.

Frans B L Hogervorst (FBL)

Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Conxi Lazaro (C)

Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, Barcelona, Spain.

Anna Jakubowska (A)

Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.

Marco Montagna (M)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Xiaoqing Chen (X)

Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Kenneth Offit (K)

Department of Medicine, Cancer Biology and Genetics, Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Peter J Hulick (PJ)

Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.

Irene L Andrulis (IL)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Annika Lindblom (A)

Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Robert L Nussbaum (RL)

Department of Medicine and Institute for Human Genetics, University of California, San Francisco, CA, USA.

Katherine L Nathanson (KL)

Department of Medicine and the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Georgia Chenevix-Trench (G)

Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Antonis C Antoniou (AC)

Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK.

Fergus J Couch (FJ)

Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

Amanda B Spurdle (AB)

Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Classifications MeSH